Scleritis and episcleritis (original) (raw)

Abstract

The data from 159 patients (217 eyes) with episscleritis and 207 patients (301 eyes) with scleritis have been investigated in detail and the results analysed with the help of a computer. Of these patients, 91 per cent were followed-up during a period of one to eight years. A new classification is presented which is as follows: Episcleritis (217 eyes) Simple episcleritis (170 eyes) Nodular episcleritis (47 eyes) Scleritis (301 eyes) Diffuse anterior scleritis (119 eyes) Nodular anterior scleritis (134 eyes) Necrotizing scleritis (42 eyes). Of these, 13 were regarded as scleromalacia perforans. Posterior scleritis (6 eyes) The diagnosis is based on an exact clinical examination which is fully described. Episcleritis has been shown to be a benign recurring condition, a mild keratitis being the only occasional complication. Episcleritis does not progress to scleritis, except in the case of herpes zoster which sometimes starts as an episcleritis with the vesicular stage of the eruption, to reappear three months later as a scleritis in the same site. No clear conclusions could be drawn as to the aetiology of episcleritis.

163

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHTON N., HOBBS H. E. Effect of cortisone on rheumatoid nodules of the sclera (scleromalacia perforans). Br J Ophthalmol. 1952 Jul;36(7):373–384. doi: 10.1136/bjo.36.7.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. FRANCESCHETTI A., BISCHLER V. La sclérite nodulaire nécrosante et ses rapports avec la scléromalacie. Ann Ocul (Paris) 1950 Sep;183(9):737–744. [PubMed] [Google Scholar]
  3. Fowler P. Rheumatic disease in patients suffering from scleral disease. Ann Rheum Dis. 1970 Mar;29(2):195–195. doi: 10.1136/ard.29.2.195-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fraunfelder F. T., Watson P. G. Evaluation of eyes enucleated for scleritis. Br J Ophthalmol. 1976 Mar;60(3):227–230. doi: 10.1136/bjo.60.3.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Graves B. "BILATERAL MESIAL SUPERFICIAL DEFICIENCY OF THE SCLERA". Br J Ophthalmol. 1937 Oct;21(10):534–538. doi: 10.1136/bjo.21.10.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Sevel D. Necrogranulomatous scleritis. Clinical and histologic features. Am J Ophthalmol. 1967 Dec;64(6):1125–1134. [PubMed] [Google Scholar]
  7. Torchia R. T., Dunn R. E., Pease P. J. Fascia lata grafting in scleromalacia perforans with lamellar corneal-scleral dissection. Am J Ophthalmol. 1968 Oct;66(4):705–709. doi: 10.1016/0002-9394(68)91293-2. [DOI] [PubMed] [Google Scholar]
  8. Vancea P., Vancea P. P., Jalobceastîi L., Colve G., Călin A. Les scléroplasties dans les affections du segment antérieur utilisant les homogreffes conservées en présence de chlorure de calcium sous vide. Arch Ophtalmol Rev Gen Ophtalmol. 1971 Oct;31(10):687–694. [PubMed] [Google Scholar]
  9. Watson P. G. Anterior segment changes in connective tissue disease. Trans Ophthalmol Soc U K. 1974 Sep;94(3):773–784. [PubMed] [Google Scholar]
  10. Watson P. G., Lobascher D. J., Sabiston D. W., Lewis-Faning E., Fowler P. D., Jones B. R. Double-blind trial of the treatment of episcleritis-scleritis with oxyphenbutazone or prednisolone. Br J Ophthalmol. 1966 Aug;50(8):463–481. doi: 10.1136/bjo.50.8.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Watson P. G., McKay D. A., Clemett R. S., Wilkinson P. Treatment of episcleritis. A double-blind trial comparing betamethasone 0.1 per cent, oxyphenbutazone 10 per cent, and placebo eye ointments. Br J Ophthalmol. 1973 Nov;57(11):866–870. doi: 10.1136/bjo.57.11.866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Williamson J. Incidence of eye disease in cases of connective tissue disease. Trans Ophthalmol Soc U K. 1974 Sep;94(3):742–752. [PubMed] [Google Scholar]